Northwire Canada EditionSaturday, July 11, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Production / Operations Routine +

Planet 13 Receives OMMU Approval for Florida BHO Extraction Facility

Florida Infrastructure Milestone Fails to Offset Q1 Earnings Deterioration and Cash Burn Concerns

Executive Summary
  • Planet 13 Holdings received approval from the Florida Office of Medical Marijuana Use (OMMU) for its BHO extraction facility on May 19, 2026.
  • The facility is a 3,465-square-foot purpose-built laboratory enabling production of concentrates including badder, shatter, crumble, sugar, sauce, and diamonds.
  • This approval completes the final major infrastructure investment in the company's Florida operational buildout.
  • Products will be available at Planet 13 Florida dispensary locations in the coming months pending individual product approvals.
  • The move allows entry into Florida's full concentrate product category for the first time, targeting a market segment that generated approximately $125 million in retail sales (Headset data).
  • This follows Q1 2026 financial results released on May 13, 2026, which showed revenue of $21.1 million (down 24.8% YoY) and a net loss of $8.1 million (widened from $2.0 million in Q1 2025).
  • Management views this as a structural improvement driving margin expansion and completing the repositioning strategy initiated with the California exit.
Material Impact
  • The approval is positive for operational capability but does not immediately resolve financial distress highlighted in earnings released just six days prior.
  • Revenue decline of 24.8% YoY in Q1 2026 suggests top-line growth remains elusive despite infrastructure completion.
  • Net loss widened significantly to $8.1 million, indicating cost-cutting measures have not yet translated into profitability or revenue stabilization.
  • Cash position stands at $16.3 million as of March 31, 2026; with a quarterly burn rate exceeding $8 million, runway is approximately two quarters without new capital.
  • The news validates the strategic pivot to Florida but acts as incremental progress rather than a fundamental turnaround catalyst given the financial backdrop.
  • Market reaction likely muted by recent earnings miss; price dropped from ~$0.25 in early May to $0.18 by mid-May prior to this announcement.
PLTH · Price
Company Overview
  • Company: Planet 13 Holdings Inc. (CSE: PLTH / OTCQX: PLNH).
  • Flagship Project: Florida Medical Marijuana Operations including retail dispensaries and the newly approved BHO extraction facility.
  • Strategic Pivot: Exit from California market completed in February 2026 to focus capital on higher-return markets Nevada and Florida.
  • Operations: Dispensaries in Florida (including DeLand, Pace) and Nevada; previously operated in California until divestiture.
  • Product Focus: Shift towards high-margin concentrates and solventless products following the ONI partnership launch in late 2025.
Read the original news release →

More from Planet 13 Holdings Inc.